Claire Lugnier
- Pharmacology top 0.5%
- Cholinesterase and Neurodegenerative Diseases 22
- Molecular Biology top 1%
- Phosphodiesterase function and regulation 101
- Receptor Mechanisms and Signaling 11
-
- Renin-Angiotensin System Studies 18
- Toxicology top 1%
- Physiology top 2%
- Nitric Oxide and Endothelin Effects 26
-
- Synthesis and Catalytic Reactions 15
- Chemical synthesis and alkaloids 14
-
- Mast cells and histamine 12
Claire Lugnier
147 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Pharmacology 1.1k
- Molecular Biology 4.0k
- Cardiology and Cardiovascular Medicine 1.2k
- Toxicology 151
- Physiology 1.1k
Countries citing papers authored by Claire Lugnier
This map shows the geographic impact of Claire Lugnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Lugnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Lugnier more than expected).
Fields of papers citing papers by Claire Lugnier
This network shows the impact of papers produced by Claire Lugnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Lugnier. The network helps show where Claire Lugnier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claire Lugnier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 30 | |
| 2 | 2020 | 12 | |
| 3 | 2019 | 19 | |
| 4 | 2014 | 7 | |
| 5 | 2014 | 36 | |
| 6 | 2011 | 12 | |
| 7 | 2010 | 14 | |
| 8 | 2010 | 55 | |
| 9 | 2009 | 30 | |
| 10 | 2009 | 121 | |
| 11 | 2008 | 19 | |
| 12 | 2005 | 21 | |
| 13 | 2002 | 176 | |
| 14 | 2000 | 28 | |
| 15 | 1999 | 51 | |
| 16 | 1999 | 34 | |
| 17 | 1995 | 11 | |
| 18 | 1993 | 10 | |
| 19 | 1990 | 25 | |
| 20 | Substituted carbostyrils as inhibitors of cyclic AMP phosphodiesterase | 1985 | 14 |
About Claire Lugnier
Claire Lugnier is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology, having authored 148 papers that have together received 5.9k indexed citations. Recurring topics across this work include Phosphodiesterase function and regulation (101 papers), Nitric Oxide and Endothelin Effects (26 papers), Cholinesterase and Neurodegenerative Diseases (22 papers), Renin-Angiotensin System Studies (18 papers), Synthesis and Catalytic Reactions (15 papers), Chemical synthesis and alkaloids (14 papers), Mast cells and histamine (12 papers) and Receptor Mechanisms and Signaling (11 papers). The work is most often cited by research in Pharmacology (1.1k citations), Molecular Biology (4.0k citations) and Cardiology and Cardiovascular Medicine (1.2k citations). Claire Lugnier has collaborated with scholars based in France, Spain and Canada. Frequent co-authors include Thérèse Keravis, J.C. Stoclet, Jean‐Claude Stoclet, Alain Le Bec, Narcisse Komas, Philippe Schoeffter, Abdurazzag Abusnina, Laure Favot, Éric Rousseau and Francisco Orallo. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.